Skip to main content
. 2024 May 3;19(5):e0302155. doi: 10.1371/journal.pone.0302155

Fig 2. Flow of participants.

Fig 2

Notes: T2DM, type 2 diabetes mellitus; NAFLD, nonalcoholic fatty liver disease; CAP, controlled attenuation parameter; LSM, liver stiffness measurement.